Zengjun Li
Impact in
- Genetics top 5%
- Chronic Lymphocytic Leukemia Research
- Hematology top 5%
- Multiple Myeloma Research and Treatments
Papers in
- Genetics 24
- Chronic Lymphocytic Leukemia Research 23
- Hematology 18
- Multiple Myeloma Research and Treatments 15
- Co-authors
- Yanlai Sun (18 shared papers)Jianjun Han (7 shared papers)Zhongfa Xu (8 shared papers)Shuhua Yi (33 shared papers)Dehui Zou (35 shared papers)Huirong Xu (5 shared papers)Lugui Qiu (34 shared papers)Yan Xu (23 shared papers)
- Journals
- Oncotarget (7 papers)Blood (5 papers)Frontiers in Immunology (3 papers)Therapeutics and Clinical Risk Management (3 papers)Frontiers in Cell and Developmental Biology (2 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Zengjun Li
93 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 92
- Genetics 227
- Hematology 225
- Oncology 403
- Cancer Research 204
- Pathology and Forensic Medicine 237
Countries citing papers authored by Zengjun Li
This map shows the geographic impact of Zengjun Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zengjun Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zengjun Li more than expected).
Fields of papers citing papers by Zengjun Li
This network shows the impact of papers produced by Zengjun Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zengjun Li. The network helps show where Zengjun Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Zengjun Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2016 | 109 | |
| 2 | 2020 | 101 | |
| 3 | 2016 | 63 | |
| 4 | 2014 | 62 | |
| 5 | 2016 | 56 | |
| 6 | 2014 | 54 | |
| 7 | 2016 | 48 | |
| 8 | 2015 | 47 | |
| 9 | 2010 | 41 | |
| 10 | 2011 | 39 | |
| 11 | 2011 | 32 | |
| 12 | 2015 | 28 | |
| 13 | 2017 | 28 | |
| 14 | 2021 | 25 | |
| 15 | 2012 | 24 | |
| 16 | 2021 | 24 | |
| 17 | 2016 | 23 | |
| 18 | 2021 | 23 | |
| 19 | 2015 | 22 | |
| 20 | 2015 | 21 |
About Zengjun Li
Zengjun Li is a scholar working on Genetics, Hematology, Pathology and Forensic Medicine, Oncology and Cancer Research, having authored 100 papers that have together received 1.3k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (23 papers), Lymphoma Diagnosis and Treatment (19 papers), Multiple Myeloma Research and Treatments (15 papers), MicroRNA in disease regulation (6 papers), Protein Degradation and Inhibitors (5 papers), Immunodeficiency and Autoimmune Disorders (4 papers), Ubiquitin and proteasome pathways (4 papers) and Viral-associated cancers and disorders (4 papers). The work is most often cited by research in Genetics (227 citations), Hematology (225 citations), Oncology (403 citations), Cancer Research (204 citations) and Pathology and Forensic Medicine (237 citations). Zengjun Li has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Yanlai Sun, Jianjun Han, Zhongfa Xu, Shuhua Yi, Dehui Zou, Huirong Xu, Lugui Qiu, Yan Xu, Jianning Li and Gang An. Their work appears in journals such as Oncotarget, Blood, Frontiers in Immunology, Therapeutics and Clinical Risk Management and Frontiers in Cell and Developmental Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.